Insider txns (12m)
36
Stock / equity
BBOT BridgeBio Oncology Therapeutics, Inc.
- Security
- Equity
- Size, estimated from filings
- Small cap ($300M – $2B)
- Insiders on record
- 14
- Latest trade on record
- October 1, 2026
BBOT (BridgeBio Oncology Therapeutics, Inc.) has 36 disclosed insider transactions from 13 insiders in the last 12 months (0 open-market buys, 12 sales, about $55K at reported prices) and 0 congressional trades from 0 members of Congress. The most recent disclosure was filed October 5, 2026.
Open-market buys / sales
0 / 12
Congress trades (12m)
0
Distinct filers (12m)
13
Share price
Price and chart by TradingView for BridgeBio Oncology Therapeutics, Inc.. US share prices here are delayed, not real-time. The trade records on this page come from government filings, not from this chart.
BBOT in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
BoughtSold
5 people account for the disclosed buying and selling in BBOT over the last 12 months; the most active is Beltran Pedro with $22K.
Insider holdings over time
Is an insider building or unwinding a position? Shares held directly after each filing.
Beltran PedroBen Yong
Beltran Pedro reported 43,529 shares held after the latest filing, against 46,670 at the first on record.
Insiders trading BBOT
Everyone who filed a Form 4 for this ticker, by number of rows on record. "Bought" and "sold" count open-market purchases (code P) and sales only; awards, option exercises and shares withheld for tax are in the row count but not in those two columns.
| Insider | Role | Rows | Bought | Sold | Value bought | Value sold | Latest |
|---|---|---|---|---|---|---|---|
| Beltran Pedro | Chief Scientific Officer | 6 | 0 | 3 | — | $22K | October 1, 2026 |
| Ben Yong | Chief Med & Dev Officer | 5 | 0 | 3 | — | $22K | October 1, 2026 |
| Cobo Marc | Principal Accounting Officer | 5 | 0 | 3 | — | $2,592 | October 1, 2026 |
| Chen Bihua | Director | 5 | 0 | 0 | — | — | July 1, 2026 |
| Elmelech Idan | COO & Principal Financial Ofcr | 3 | 0 | 2 | — | $4,027 | October 1, 2026 |
| Mehra Uneek | Chief Financial Officer | 3 | 0 | 1 | — | $4,732 | April 1, 2026 |
| Wallace Eli M. | Chief Executive Officer | 3 | 0 | 0 | — | — | January 1, 2026 |
| Lebowitz Peter F | Director | 2 | 0 | 0 | — | — | June 16, 2026 |
| Bauer Jake | Director | 1 | 0 | 0 | — | — | June 16, 2026 |
| Kelleher Raymond J. | Director | 1 | 0 | 0 | — | — | June 16, 2026 |
| Kumar Neil | Chief Executive Officer | 1 | 0 | 0 | — | — | June 16, 2026 |
| MCCORMICK FRANK | Director | 1 | 0 | 0 | — | — | June 16, 2026 |
| Tipirneni Praveen P. | Director | 1 | 0 | 0 | — | — | June 16, 2026 |
| BridgeBio Pharma LLC | Insider | 1 | 0 | 0 | — | — | October 10, 2025 |
What kind of transactions these are 4 Form 4 codes
| Code | Meaning | Rows | Shares | Value at reported prices |
|---|---|---|---|---|
| A | Grant or award | 20 | 5,545,956 | — |
| F | Shares withheld for tax | 12 | 7,946 | $55K |
| J | Other acquisition or disposal | 5 | 9,841,092 | — |
| D | Sale back to the company | 1 | 1,114,400 | — |
What each code means: Form 4 transaction codes.
Insider transactions
| Filer | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Cobo Marc | Sell F | October 1, 2026 | October 5, 2026 | 4d | 126 | $4 | $496 | Form 4 ↗ | ||
| Elmelech Idan | Sell F | October 1, 2026 | October 5, 2026 | 4d | 343 | $4 | $1,351 | Form 4 ↗ | ||
| Beltran Pedro | Sell F | October 1, 2026 | October 5, 2026 | 4d | 1,047 | $4 | $4,125 | Form 4 ↗ | ||
| Ben Yong | Sell F | October 1, 2026 | October 5, 2026 | 4d | 1,047 | $4 | $4,125 | Form 4 ↗ | ||
| Cobo Marc | Other A | September 10, 2026 | September 14, 2026 | 4d | 43,700 | — | — | derivative | Form 4 ↗ | |
| Cobo Marc | Sell F | September 10, 2026 | September 14, 2026 | 4d | 203 | $6 | $1,121 | Form 4 ↗ | ||
| Cobo Marc | Other A | September 10, 2026 | September 14, 2026 | 4d | 9,038 | — | — | Form 4 ↗ | ||
| Cobo Marc | Sell F | July 1, 2026 | July 6, 2026 | 5d | 125 | $8 | $975 | late | Form 4 ↗ | |
| Elmelech Idan | Sell F | July 1, 2026 | July 6, 2026 | 5d | 343 | $8 | $2,675 | late | Form 4 ↗ | |
| Ben Yong | Sell F | July 1, 2026 | July 6, 2026 | 5d | 1,047 | $8 | $8,167 | late | Form 4 ↗ | |
| Beltran Pedro | Sell F | July 1, 2026 | July 6, 2026 | 5d | 1,047 | $8 | $8,167 | late | Form 4 ↗ | |
| Chen Bihua | Other J | July 1, 2026 | July 6, 2026 | 5d | 130,865 | — | — | lateindirect | Form 4 ↗ | |
| Chen Bihua | Other J | July 1, 2026 | July 6, 2026 | 5d | 1,704,862 | — | — | lateindirect | Form 4 ↗ | |
| Chen Bihua | Other J | July 1, 2026 | July 6, 2026 | 5d | 2,692,459 | — | — | lateindirect | Form 4 ↗ | |
| Chen Bihua | Other J | July 1, 2026 | July 6, 2026 | 5d | 4,528,186 | — | — | lateindirect | Form 4 ↗ | |
| Tipirneni Praveen P. | Other A | June 16, 2026 | June 18, 2026 | 2d | 31,675 | — | — | derivative | Form 4 ↗ | |
| MCCORMICK FRANK | Other A | June 16, 2026 | June 18, 2026 | 2d | 31,675 | — | — | derivative | Form 4 ↗ | |
| Lebowitz Peter F | Other A | June 16, 2026 | June 18, 2026 | 2d | 7,289 | — | — | derivative | Form 4 ↗ | |
| Kelleher Raymond J. | Other A | June 16, 2026 | June 18, 2026 | 2d | 31,675 | — | — | derivative | Form 4 ↗ | |
| Chen Bihua | Other A | June 16, 2026 | June 18, 2026 | 2d | 31,675 | — | — | derivative | Form 4 ↗ | |
| Bauer Jake | Other A | June 16, 2026 | June 18, 2026 | 2d | 31,675 | — | — | derivative | Form 4 ↗ | |
| Kumar Neil | Other A | June 16, 2026 | June 18, 2026 | 2d | 31,675 | — | — | derivative | Form 4 ↗ | |
| Elmelech Idan | Other A | May 10, 2026 | May 12, 2026 | 2d | 758,222 | — | — | derivative | Form 4 ↗ | |
| Beltran Pedro | Other A | May 10, 2026 | May 12, 2026 | 2d | 1,103,837 | — | — | derivative | Form 4 ↗ | |
| Ben Yong | Sell F | April 1, 2026 | May 5, 2026 | 34d | 1,047 | $9 | $9,454 | late | Form 4 ↗ | |
| Beltran Pedro | Sell F | April 1, 2026 | May 5, 2026 | 34d | 1,047 | $9 | $9,454 | late | Form 4 ↗ | |
| Mehra Uneek | Sell F | April 1, 2026 | May 5, 2026 | 34d | 524 | $9 | $4,732 | late | Form 4 ↗ | |
| Lebowitz Peter F | Other A | March 24, 2026 | March 26, 2026 | 2d | 63,350 | — | — | derivative | Form 4 ↗ | |
| Mehra Uneek | Other A | March 10, 2026 | March 12, 2026 | 2d | 105,000 | — | — | derivative | Form 4 ↗ | |
| Mehra Uneek | Other A | March 10, 2026 | March 12, 2026 | 2d | 23,330 | — | — | Form 4 ↗ | ||
| Beltran Pedro | Other A | March 10, 2026 | March 12, 2026 | 2d | 210,000 | — | — | derivative | Form 4 ↗ | |
| Beltran Pedro | Other A | March 10, 2026 | March 12, 2026 | 2d | 46,670 | — | — | Form 4 ↗ | ||
| Ben Yong | Other A | March 10, 2026 | March 12, 2026 | 2d | 210,000 | — | — | derivative | Form 4 ↗ | |
| Ben Yong | Other A | March 10, 2026 | March 12, 2026 | 2d | 46,670 | — | — | Form 4 ↗ | ||
| Wallace Eli M. | Other A | January 1, 2026 | January 5, 2026 | 4d | 1,114,400 | — | — | derivative | Form 4 ↗ | |
| Wallace Eli M. | Option / conversion D | December 10, 2025 | December 12, 2025 | 2d | 1,114,400 | — | — | derivative | Form 4 ↗ | |
| BridgeBio Pharma LLC | Other J | October 10, 2025 | October 16, 2025 | 6d | 784,720 | — | — | late | Form 4 ↗ | |
| Wallace Eli M. | Other A | October 2, 2025 | October 6, 2025 | 4d | 1,614,400 | — | — | derivative | Form 4 ↗ |
Congressional trades
No member of Congress has disclosed a trade in this ticker in the filings we have parsed.
Related stocks
Tickers traded by the same people who traded BBOT, by number of filers in common. It shows overlap in public filings and nothing else.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 30 | 38 | October 6, 2025 | October 5, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insider rows are Form 4 filings for this issuer from SEC EDGAR; congressional rows are periodic transaction reports parsed from the House Clerk and the Senate eFD. Values use the reported price for Form 4 and the disclosed range for Congress. See methodology and corrections.
Not investment advice. Disclosures are shown as filed and may lag the trade or be amended. No recommendation is made or implied.